With approximately 2,000 new cases per year, childhood cancer is relatively rare compared to adults. More than 90 percent of young patients can already be included in standardized national and international registries and therapy optimization studies according to the German Society for Pediatric Hematology and Oncology (GPOH) at initial diagnosis.
At the Department of Pediatric Oncology, Hematology, Immunology and Pneumology (Center for Pediatric and Adolescent Medicine) at Heidelberg University Hospital (UKHD), children and adolescents with cancer and other complex diseases of the blood and coagulation system are treated as outpatients and inpatients. The Pediatric Oncology Center at Heidelberg University Hospital (UKHD) has been certified according to the criteria of the German Cancer Society (DKG) since 2019.
The oncological and hematological part of the Department of Pediatric Oncology, Hematology, Immunology and Pneumology corresponds to the clinical program (Program I) of the Hopp Children's Tumor Center Heidelberg (KiTZ). The KiTZ is a joint institution of the German Cancer Research Center (DKFZ), the UKHD and the University of Heidelberg. Its goal is to scientifically investigate the biology of childhood cancer and severe blood diseases and to closely link promising research approaches with patient care.